Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Sep. 28, 2024
Dec. 30, 2023
Current assets:    
Cash and cash equivalents $ 3,897 $ 3,933
Short-term investments 647 1,840
Accounts receivable, net 7,241 5,376
Inventories 5,374 4,351
Receivables from related parties 29 9
Prepaid expenses and other current assets 1,547 1,259
Total current assets 18,735 16,768
Property and equipment, net 1,669 1,589
Operating lease right-of-use assets 647 633
Goodwill 24,839 24,262
Acquisition-related intangibles, net 19,572 21,363
Investment: equity method 137 99
Deferred tax assets 1,183 366
Other non-current assets 2,854 2,805
Total assets 69,636 67,885
Current liabilities:    
Accounts payable 2,530 2,055
Payables to related parties 461 363
Accrued liabilities 4,120 3,082
Current portion of long-term debt, net 0 751
Other current liabilities 389 438
Total current liabilities 7,500 6,689
Long-term debt, net of current portion 1,720 1,717
Long-term operating lease liabilities 518 535
Deferred tax liabilities 1,162 1,202
Other long-term liabilities 1,751 1,850
Commitments and contingencies (See Note 13)
Capital stock:    
Common stock, par value $0.01; shares authorized: 2,250; shares issued: 1,678 and 1,663; shares outstanding: 1,623 and 1,616 17 17
Additional paid-in capital 60,896 59,676
Treasury stock, at cost (shares held: 55 and 47) (5,812) (4,514)
Retained earnings 1,882 723
Accumulated other comprehensive income (loss) 2 (10)
Total stockholders’ equity 56,985 55,892
Total liabilities and stockholders’ equity $ 69,636 $ 67,885
Common stock, outstanding (in shares) 1,623 1,616
Common stock, par value (in dollars per share) $ 0.01  
Common stock, authorized (in shares) 2,250  
Common stock, issued (in shares) 1,678 1,663